Hero Background

Cut through the noise.
Trade on the signal.

A weekly synthesis of institutional-grade financial reports and market mechanics.

No spam. Unsubscribe anytime.

All Reports

Filters

Companies

Tickers

Authors

Latest Reports

Ticker: ACHV Author: Hunterbrook

“Put it in the water!” - How a Toxic Tree May Save Thousands of Smokers

Achieve Life Sciences ACHV stock analysis: cytisinicline smoking cessation breakthrough therapy with Phase 3 trial success offset by financial runway crisis, supply chain risks, and promotional stock activity. Independent equity research with disclosed long position by Hunterbrook Capital

Dec 30, 2025 7 min read
Author: Two Natural Capital

Antibodies, Antibody Fragments, and Peptides: Targeting Muscular Diseases with RNA

RNA therapeutics targeting muscular diseases face unresolved delivery and nuclear access challenges that companies may be understating, with PepGen's 53.7% splicing correction dwarfing Avidity's 16% and Dyne's 27% — raising questions about measurement consistency or overstated claims

Dec 19, 2025 6 min read
Author: Viceroy Research Company: Vedanta Limited (VEDL.NS)

Vedanta – ITD Alleges Tax Evasion by VRL

India's Income Tax Department alleges Vedanta used an offshore Mauritius entity to evade ~$145M in taxes, with potential 200% penalties, while six statutory demands and an adverse order were allegedly never disclosed to bondholders despite Vedanta's own disclosure policy

Dec 19, 2025 4 min read
Author: Capybara Research Ticker: NUTX

Problems at Nutex, Part Two: Misunderstood by Investors and Facing a Revenue Cliff As Schemes Unravel

Capybara Research exposes Nutex Health's alleged systematic billing fraud, revealing a 228% revenue spike, massive receivables inflation, and potential $300M markdown risk through fraudulent arbitration practices with HaloMD

Dec 16, 2025 9 min read
Author: Bleecker Street Research Ticker: VIA

Via Transportation (VIA): Road to Nowhere

Via Transportation (VIA) bearish research reveals 72% revenue from labor services, inflated metrics, software decoupling risks, and potential 60% downside as federal grants expire, challenging its software platform narrative

Dec 16, 2025 7 min read
Ticker: RDNT Author: Hunterbrook

RadNet: The AI Story That Doesn’t Add Up

RadNet's AI transformation exposed: Short report reveals accounting manipulations, artificial growth, and valuation disconnect in medical imaging company, challenging inflated tech narrative and market positioning

Dec 16, 2025 6 min read
Ticker: PAYS Author: Hunterbrook

NEW: Permian Confirms Methane Release After Hunterbrook Investigation

Hunterbrook Capital exposes Permian Resources' massive methane leak near Carlsbad, NM, revealing 15x higher emissions, toxic benzene exposure, and potential environmental and health risks across 80-square-mile region

Dec 15, 2025 5 min read
Author: Viceroy Research Ticker: VEDL.NS

Vedanta – ESL’s Debt Raise Shows Lack of Options

Viceroy Research exposes Vedanta Limited's financial manipulation: ESL Steel's ₹2,000 crore debt raise masks liquidity crisis, reveals unsustainable business model with negative cash flow and questionable accounting practices

Dec 2, 2025 3 min read
Ticker: SOC Author: Hunterbrook

BREAKING: Sable Is Running Out Of Money

HunterBrook exposes Sable Offshore Corporation's critical financial crisis: $1B Exxon debt, $2.3B production funding gap, zero revenue, imminent bankruptcy risk, and unsustainable cash burn threatening offshore energy venture's survival

Nov 14, 2025 3 min read
Ticker: PZZA Author: Hunterbrook

$PZZA Gate, Part 2: The Network Behind Fake Papa Johns News

Explosive investigation reveals Dubai-based UK operators manipulated Papa Johns stock through coordinated disinformation campaign, using low-cost fake news sites to trigger 18% market surge and potential options trading profits

Nov 12, 2025 3 min read
Author: Spruce Point Capital Management Ticker: IPX

IperionX Ltd. - Spruce Point Capital Management LLC

Spruce Point exposes IperionX Ltd. (IPX) as a massively overvalued titanium tech company with unproven HAMR technology, questionable management history, and minimal revenue potential, suggesting 70-95% downside risk

Nov 12, 2025 3 min read
Author: Viceroy Research Ticker: ABR

Arbor – Oct 2025 CLO Update

Viceroy Research exposes Arbor Realty Trust's alleged CLO data manipulation, revealing $730M in loan modifications, 0.00% interest rates, and systematic financial reporting fabrication that potentially misleads investors about portfolio performance

Oct 31, 2025 3 min read

The Signal. No Noise.

Join 50,000+ investors receiving our weekly synthesis.